Stress Urinary Incontinence Study to Assess Safety and Efficacy of Muvon's Muscle Precursor Cell Therapy

计划入组 30 人 · 首次发布于 2022 年 9 月 9 日

Multisystem Cell Therapy for Improvement of Urinary Continence

计划入组 10 人 · 首次发布于 2018 年 2 月 20 日

Investigating Endothelial Precursor Cells (EPCs)

计划入组 84 人 · 首次发布于 2003 年 8 月 11 日

autologous muscle precursor cells

Precursor

Primary human muscle stem cells

STEM CELLS ARABIA

Jordan

Ace Cells Lab Limited

KLSMC Stem Cells, Inc.

MUVON Therapeutics Reports Breakthrough Phase 2 Results for Muscle Cell-Based Stress Urinary Incontinence Therapy

Lipid Nanoparticles Enable Durable CRISPR Gene Editing in Muscle Stem Cells for Duchenne Muscular Dystrophy

HDAC Inhibition in Muscle Cells Enhances Bone Regeneration via Extracellular Vesicles